All tested variants (AR-FL, AR-V1, AR-V3, AR-V4 and AR-V7) displayed similar expression patterns, showing rarer expression in ccRCC tumors than in control tissue (normal expression > tumor expression in 56%, 56%, 52%, 64% and 48%, respectively) (Table 3). The gene discussed is AR; the disease is neoplasm.